| Category : |
Pharmaceuticals and Biochemicals |
 |
| CAS NO : |
842133-18-0 |
| EC NO : |
|
| MF : |
C24H25FO5S |
| MW : |
444.52 |
| Specification : |
99.9%min |
| Packing : |
standard packaging |
| Product description : |
Canagliflozin (INN, trade name Invokana or Sulisent) is a drug of the gliflozin class or subtype 2 sodium-glucose transport (SGLT-2) inhibitors used for the treatment of type 2 diabetes. |
| Uses : |
Hypertension |
| Synonyms : |
(1s)-1,5-anhydro-1-c-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-d-glucitol;1-(β-D-glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienyl-methyl) benzene;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;Canaglifozin; |
| Molecular Structure : |
 |